{"artifact":{"id":"experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51","artifact_type":"experiment","entity_ids":"[\"ACSL1, PPAR\\u03b3, CYP7A1, SCD1, ACLY, SREBF1, CPT1A, ACC1, APOE4\"]","title":"Multi-omics analysis of myricanol effects on gene expression and microRNA regulation","quality_score":0.88,"created_by":"experiment_extractor","provenance_chain":"[]","content_hash":"ddfc0e927ce687011ed8da5a4c25fb29315d242a9d1f7f309aa081f6f286e3df","metadata":{"_origin":{"url":null,"type":"internal","tracked_at":"2026-04-10T22:46:31.354067"},"p_value":null,"protocol":"RNA sequencing for transcriptome analysis, metabolomics for metabolite profiling, pathway enrichment analysis for functional annotation","effect_size":null,"sample_size":null,"source_pmid":"41520958","extracted_at":"2026-04-10T15:46:31.270380","_schema_version":1,"experiment_type":"gene_expression","success_criteria":"Significant differential expression of target genes, pathway enrichment in lipid metabolism, coordinated regulation of metabolic networks","expected_outcomes":"Upregulation of beneficial metabolic genes, modulation of lipid metabolism pathways, altered microRNA expression profiles","statistical_methods":null},"created_at":"2026-04-10T22:46:31-07:00","updated_at":"2026-04-10T22:46:31-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-10T22:46:31-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"c1fc9181-9da6-451e-9a16-93b77e12c9d3","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"experiment_extractor"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-genes-srebf1","link_type":"related","strength":0.1,"evidence":null},{"target_artifact_id":"wiki-genes-scd1","link_type":"related","strength":0.1,"evidence":null},{"target_artifact_id":"experiment-exp-7b408249-2294-4c7f-9720-f30df6c60822","link_type":"related","strength":0.1,"evidence":null},{"target_artifact_id":"experiment-exp-08739af4-5a7c-4257-b409-749272837c47","link_type":"related","strength":0.1,"evidence":null},{"target_artifact_id":"wiki-ideas-apoe4-lipid-metabolism-optimization","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: APOE4"},{"target_artifact_id":"wiki-mechanisms-rna-splicing-4r-tauopathies-comparison","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-technologies-rna-editing-therapeutics","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-g-quadruplexes-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-therapeutics-investment-synthesis","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-targeted-therapies-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-metabolism-alzheimers-disease","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-investment-rna-therapeutics","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-genes-rbfox3","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-therapeutics-rna-therapeutics-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-cbs-rna-metabolism-dysfunction","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-metabolism-dysregulation","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-therapeutics-ad-rna-therapeutics-companies","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-granule-dysfunction-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-toxicity","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-processing","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-therapeutics-rna-targeting-therapies-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-proteins-acsl1-protein","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: ACSL1"},{"target_artifact_id":"wiki-mechanisms-rna-dysregulation-ad","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-genes-rbfox2","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-therapeutics-rna-targeting-therapy-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-metabolism-4r-tauopathies","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-proteins-scd1-protein","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: SCD1"},{"target_artifact_id":"wiki-mechanisms-acly-alpha-synuclein-autophagy","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: ACLY"},{"target_artifact_id":"wiki-mechanisms","link_type":"related","strength":0.54,"evidence":"Reverse: Title match: Mechanisms"},{"target_artifact_id":"wiki-mechanisms-rna-stability","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-therapeutics-rnai-therapies-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-cell-types-apoe4-homozygous-astrocytes","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: APOE4"},{"target_artifact_id":"wiki-diseases-apoe4","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APOE4"},{"target_artifact_id":"wiki-mechanisms-apoe4-alzheimers","link_type":"related","strength":0.7200000000000001,"evidence":"Reverse: Gene target: APOE4"},{"target_artifact_id":"wiki-mechanisms-rna-splicing-defects","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-splicing","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-mechanisms-rna-metabolism","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-investment-rna-therapeutics-neurodegeneration","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-proteins-ifng-protein","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: IFN"},{"target_artifact_id":"wiki-ideas-apoe4-lipid-homeostasis-modulator","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: APOE4"},{"target_artifact_id":"wiki-genes-rbfox1","link_type":"related","strength":0.63,"evidence":"Reverse: Gene mention: RNA"},{"target_artifact_id":"wiki-genes-srebf1","link_type":"mentions","strength":0.5,"evidence":"Entity SREBF1 in experiment"},{"target_artifact_id":"wiki-genes-scd1","link_type":"mentions","strength":0.5,"evidence":"Entity SCD1 in experiment"}],"incoming_links":[{"source_artifact_id":"experiment-exp-3f75797a-bb15-442f-9881-fb559f0b6f72","link_type":"related","strength":0.2727272727272727,"evidence":null},{"source_artifact_id":"experiment-exp-feac9870-b737-4a77-8438-302f8eed1e47","link_type":"related","strength":0.18181818181818182,"evidence":null},{"source_artifact_id":"wiki-proteins-scd1-protein","link_type":"mentions","strength":0.8,"evidence":"Gene target: SCD1"},{"source_artifact_id":"wiki-mechanisms-acly-alpha-synuclein-autophagy","link_type":"mentions","strength":0.7,"evidence":"Gene mention: ACLY"},{"source_artifact_id":"wiki-mechanisms","link_type":"mentions","strength":0.6,"evidence":"Title match: Mechanisms"},{"source_artifact_id":"wiki-mechanisms-rna-stability","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-therapeutics-rnai-therapies-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-cell-types-apoe4-homozygous-astrocytes","link_type":"mentions","strength":0.8,"evidence":"Gene target: APOE4"},{"source_artifact_id":"wiki-diseases-apoe4","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APOE4"},{"source_artifact_id":"wiki-mechanisms-apoe4-alzheimers","link_type":"mentions","strength":0.8,"evidence":"Gene target: APOE4"},{"source_artifact_id":"wiki-mechanisms-rna-splicing-defects","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-splicing","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-genes-scd1","link_type":"mentions","strength":0.7,"evidence":"Gene mention: SCD1"},{"source_artifact_id":"wiki-investment-rna-therapeutics-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-proteins-ifng-protein","link_type":"mentions","strength":0.7,"evidence":"Gene mention: IFN"},{"source_artifact_id":"wiki-ideas-apoe4-lipid-homeostasis-modulator","link_type":"mentions","strength":0.7,"evidence":"Gene mention: APOE4"},{"source_artifact_id":"wiki-genes-rbfox1","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-4r-tauopathies","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-ideas-apoe4-lipid-metabolism-optimization","link_type":"mentions","strength":0.8,"evidence":"Gene target: APOE4"},{"source_artifact_id":"wiki-mechanisms-rna-splicing-4r-tauopathies-comparison","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-technologies-rna-editing-therapeutics","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-g-quadruplexes-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-therapeutics-investment-synthesis","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-targeted-therapies-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-alzheimers-disease","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-investment-rna-therapeutics","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-genes-rbfox3","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-genes-srebf1","link_type":"mentions","strength":0.8,"evidence":"Gene target: SREBF1"},{"source_artifact_id":"wiki-therapeutics-rna-therapeutics-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-cbs-rna-metabolism-dysfunction","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-metabolism-dysregulation","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-therapeutics-ad-rna-therapeutics-companies","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-granule-dysfunction-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-toxicity","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-mechanisms-rna-processing","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-therapeutics-rna-targeting-therapies-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-proteins-acsl1-protein","link_type":"mentions","strength":0.7,"evidence":"Gene mention: ACSL1"},{"source_artifact_id":"wiki-mechanisms-rna-dysregulation-ad","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-genes-rbfox2","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-therapeutics-rna-targeting-therapy-neurodegeneration","link_type":"mentions","strength":0.7,"evidence":"Gene mention: RNA"},{"source_artifact_id":"wiki-hypotheses","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/hypotheses"},{"source_artifact_id":"wiki-companies","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/companies"},{"source_artifact_id":"wiki-investment-landscape","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/investment-landscape"},{"source_artifact_id":"wiki-diagnostics","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/diagnostics"},{"source_artifact_id":"wiki-ideas","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/ideas"},{"source_artifact_id":"wiki-cell-types","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/cell-types"},{"source_artifact_id":"wiki-all-pages","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/all-pages"},{"source_artifact_id":"wiki-researchers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/researchers"},{"source_artifact_id":"wiki-therapeutics-combination-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-combination-therapy"},{"source_artifact_id":"wiki-therapeutics-gene-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-gene-therapy"},{"source_artifact_id":"wiki-therapeutics-section-45-neuroinflammation-imaging-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-section-45-neuroinflammation-imaging-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-sigma-1-receptor-agonists","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-sigma-1-receptor-agonists"},{"source_artifact_id":"wiki-therapeutics-e2814","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-e2814"},{"source_artifact_id":"wiki-therapeutics-antibody-comparison-matrix","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-antibody-comparison-matrix"},{"source_artifact_id":"wiki-therapeutics-donanemab","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-donanemab"},{"source_artifact_id":"wiki-therapeutics-tau-immunotherapies-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-tau-immunotherapies-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-anti-amyloid-antibody-clinical-trials","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-anti-amyloid-antibody-clinical-trials"},{"source_artifact_id":"wiki-therapeutics-neuroprotective-peptides","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-neuroprotective-peptides"},{"source_artifact_id":"wiki-therapeutics-section-107-crispr-therapies-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-section-107-crispr-therapies-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-phage-display-directed-evolution-tau","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-phage-display-directed-evolution-tau"},{"source_artifact_id":"wiki-therapeutics-section-147-telehealth-remote-monitoring-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-section-147-telehealth-remote-monitoring-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-trem2-modulator-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-trem2-modulator-therapy"},{"source_artifact_id":"wiki-therapeutics-antibody-therapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-antibody-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-tau-targeted-therapeutics","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-tau-targeted-therapeutics"},{"source_artifact_id":"wiki-therapeutics-exosome-drug-delivery-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-exosome-drug-delivery-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-gene-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-gene-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-tau-small-molecules","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-tau-small-molecules"},{"source_artifact_id":"wiki-therapeutics-section-102-proteostasis-network-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-section-102-proteostasis-network-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-section-188-advanced-lipidomics-membrane-therapy-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-section-188-advanced-lipidomics-membrane-therapy-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-section-152-robotics-assistive-devices-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-section-152-robotics-assistive-devices-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-targeted-protein-degradation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-targeted-protein-degradation"},{"source_artifact_id":"wiki-therapeutics-section-216-pharmacogenomics-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-section-216-pharmacogenomics-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-personalized-treatment-plan-atypical-parkinsonism","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-personalized-treatment-plan-atypical-parkinsonism"},{"source_artifact_id":"wiki-therapeutics-ipamorelin","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-ipamorelin"},{"source_artifact_id":"wiki-therapeutics-mrna-therapy-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-mrna-therapy-parkinsons"},{"source_artifact_id":"wiki-therapeutics-section-193-advanced-integrated-cell-stress-response-therapy-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-section-193-advanced-integrated-cell-stress-response-therapy-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-section-148-advanced-nutritional-biochemistry-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 7x in wiki/therapeutics-section-148-advanced-nutritional-biochemistry-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-retinoid-pathway-modulator-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-retinoid-pathway-modulator-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-apolipoprotein-lipid-transport-therapy-landscape","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-apolipoprotein-lipid-transport-therapy-landscape"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing-parkinsons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-crispr-gene-editing-parkinsons"},{"source_artifact_id":"wiki-therapeutics-protective-strategies-cbs-psp","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-protective-strategies-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-small-molecule-drugs","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-small-molecule-drugs"},{"source_artifact_id":"wiki-therapeutics-liposome-brain-delivery","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-liposome-brain-delivery"},{"source_artifact_id":"wiki-therapeutics-chronic-traumatic-encephalopathy-cte-treatment","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-chronic-traumatic-encephalopathy-cte-treatment"},{"source_artifact_id":"wiki-therapeutics-bepranemab","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-bepranemab"},{"source_artifact_id":"wiki-therapeutics-proteostasis-therapeutics-investment","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-proteostasis-therapeutics-investment"},{"source_artifact_id":"wiki-therapeutics-lu-af87908","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-lu-af87908"},{"source_artifact_id":"wiki-therapeutics-gene-editing-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-gene-editing-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-section-218-advanced-nutritional-genomics-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-section-218-advanced-nutritional-genomics-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-myelin-repair","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-myelin-repair"},{"source_artifact_id":"wiki-therapeutics-florbetapir","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-florbetapir"},{"source_artifact_id":"wiki-therapeutics-section-200-advanced-computational-neuroscience-ai-drug-discovery-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-section-200-advanced-computational-neuroscience-ai-drug-discovery-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-non-pharmacological-interventions","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-non-pharmacological-interventions"},{"source_artifact_id":"wiki-therapeutics-section-134-advanced-lipidomics-membrane-therapy-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-section-134-advanced-lipidomics-membrane-therapy-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-pharmacogenomics-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-pharmacogenomics-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-cell-based-immunotherapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-cell-based-immunotherapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-donepezil","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-donepezil"},{"source_artifact_id":"wiki-therapeutics-mtor-inhibitors","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-mtor-inhibitors"},{"source_artifact_id":"wiki-therapeutics-biomarker-guided-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-biomarker-guided-therapy"},{"source_artifact_id":"wiki-therapeutics-lecanemab","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-lecanemab"},{"source_artifact_id":"wiki-therapeutics-targeted-protein-degradation-protacs","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-targeted-protein-degradation-protacs"},{"source_artifact_id":"wiki-therapeutics-ketone-body-therapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-ketone-body-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-hormone-neuroprotection-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-hormone-neuroprotection-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-immunotherapy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-immunotherapy"},{"source_artifact_id":"wiki-therapeutics-section-186-crispr-base-editing-therapeutics-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-section-186-crispr-base-editing-therapeutics-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-crispr-gene-editing"},{"source_artifact_id":"wiki-therapeutics-sglt2-inhibitors-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-sglt2-inhibitors-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-apoe-genotype-guided-prevention","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 17x in wiki/therapeutics-apoe-genotype-guided-prevention"},{"source_artifact_id":"wiki-therapeutics-galectin-3-inhibitor-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-galectin-3-inhibitor-therapy"},{"source_artifact_id":"wiki-therapeutics-sod1-targeting-therapies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-sod1-targeting-therapies"},{"source_artifact_id":"wiki-therapeutics-crispr-brain-delivery","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-crispr-brain-delivery"},{"source_artifact_id":"wiki-therapeutics-exercise-physical-activity-neuroprotection","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-exercise-physical-activity-neuroprotection"},{"source_artifact_id":"wiki-therapeutics-aducanumab","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-aducanumab"},{"source_artifact_id":"wiki-therapeutics-bbb-penetrant-antibodies","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-bbb-penetrant-antibodies"},{"source_artifact_id":"wiki-therapeutics-lrrk2-targeting-therapies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-lrrk2-targeting-therapies"},{"source_artifact_id":"wiki-therapeutics-asm-inhibitors-small-biotech","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-asm-inhibitors-small-biotech"},{"source_artifact_id":"wiki-therapeutics-cbs-psp-clinical-trials-guide","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-cbs-psp-clinical-trials-guide"},{"source_artifact_id":"wiki-therapeutics-advanced-immunotherapy-platforms-tau","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-advanced-immunotherapy-platforms-tau"},{"source_artifact_id":"wiki-therapeutics-section-198-advanced-precision-medicine-implementation-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-section-198-advanced-precision-medicine-implementation-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-tau-kinase-inhibitors","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-tau-kinase-inhibitors"},{"source_artifact_id":"wiki-therapeutics-spam1-sirt6-modulator","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-spam1-sirt6-modulator"},{"source_artifact_id":"wiki-therapeutics-tau-immunotherapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-tau-immunotherapy"},{"source_artifact_id":"wiki-therapeutics-trem2-agonists","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-trem2-agonists"},{"source_artifact_id":"wiki-therapeutics-neuroinflammation-targeting-therapies","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-neuroinflammation-targeting-therapies"},{"source_artifact_id":"wiki-therapeutics-nanoparticle-brain-delivery","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-nanoparticle-brain-delivery"},{"source_artifact_id":"wiki-therapeutics-anti-amyloid-therapeutics","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 12x in wiki/therapeutics-anti-amyloid-therapeutics"},{"source_artifact_id":"wiki-therapeutics-omega-3-fatty-acids-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 7x in wiki/therapeutics-omega-3-fatty-acids-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-section-209-glp-1-receptor-agonists-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-section-209-glp-1-receptor-agonists-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-csf1r-inhibitors-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-csf1r-inhibitors-parkinsons"},{"source_artifact_id":"wiki-therapeutics-section-135-telomere-biology-anti-aging-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/therapeutics-section-135-telomere-biology-anti-aging-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-metabolic-therapy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-metabolic-therapy"},{"source_artifact_id":"wiki-therapeutics-section-113-emerging-gene-therapy-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-section-113-emerging-gene-therapy-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-molecular-chaperone-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-molecular-chaperone-therapy"},{"source_artifact_id":"wiki-therapeutics-promising-clinical-trials-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/therapeutics-promising-clinical-trials-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-antisense-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-antisense-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-lrrk2-kinase-targeting-therapies","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-lrrk2-kinase-targeting-therapies"},{"source_artifact_id":"wiki-therapeutics-section-199-computational-pharmacology-cbs-psp","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-section-199-computational-pharmacology-cbs-psp"},{"source_artifact_id":"wiki-therapeutics-gamma-secretase-modulators","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-gamma-secretase-modulators"},{"source_artifact_id":"wiki-therapeutics-omega-3-fatty-acids-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/therapeutics-omega-3-fatty-acids-parkinsons"},{"source_artifact_id":"wiki-therapeutics-crispr-cas9-gene-therapy-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/therapeutics-crispr-cas9-gene-therapy-neurodegeneration"},{"source_artifact_id":"wiki-therapeutics-crispr-gene-editing-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/therapeutics-crispr-gene-editing-neurodegeneration"},{"source_artifact_id":"wiki-clinical-trials-alz-801-phase-3-apolloe4","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 10x in wiki/clinical-trials-alz-801-phase-3-apolloe4"},{"source_artifact_id":"wiki-clinical-trials-staree-statin-dementia-prevention","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/clinical-trials-staree-statin-dementia-prevention"},{"source_artifact_id":"wiki-clinical-trials-nct05400330-lx1001-ltfu","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 23x in wiki/clinical-trials-nct05400330-lx1001-ltfu"},{"source_artifact_id":"wiki-clinical-trials-explas-nct05068830","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/clinical-trials-explas-nct05068830"},{"source_artifact_id":"wiki-clinical-trials-nct07094516-novartis-alzheimers-phase2","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/clinical-trials-nct07094516-novartis-alzheimers-phase2"},{"source_artifact_id":"wiki-clinical-trials-nct03634007-lx1001-phase-1-2","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 29x in wiki/clinical-trials-nct03634007-lx1001-phase-1-2"},{"source_artifact_id":"wiki-clinical-trials-nct07392723-ala-apoe4-mci","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 29x in wiki/clinical-trials-nct07392723-ala-apoe4-mci"},{"source_artifact_id":"wiki-mechanisms-amyloid-aggregation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-amyloid-aggregation"},{"source_artifact_id":"wiki-clinical-trials-nct03848312","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/clinical-trials-nct03848312"},{"source_artifact_id":"wiki-clinical-trials-dbs-nbm-nct07218081","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/clinical-trials-dbs-nbm-nct07218081"},{"source_artifact_id":"wiki-hypotheses-oligodendrocyte-myelin-dysfunction-parkinsons","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/hypotheses-oligodendrocyte-myelin-dysfunction-parkinsons"},{"source_artifact_id":"wiki-hypotheses-apoe-contributes-alzheimers-disease-regulat","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 55x in wiki/hypotheses-apoe-contributes-alzheimers-disease-regulat"},{"source_artifact_id":"wiki-hypotheses-metabolic-dysfunction-type-3-diabetes-alzheimers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 12x in wiki/hypotheses-metabolic-dysfunction-type-3-diabetes-alzheimers"},{"source_artifact_id":"wiki-hypotheses-neural-stem-cell-failure-alzheimers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/hypotheses-neural-stem-cell-failure-alzheimers"},{"source_artifact_id":"wiki-datasets-amp-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/datasets-amp-ad"},{"source_artifact_id":"wiki-ideas-vascular-cognitive-impairment-prevention-bundle","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/ideas-vascular-cognitive-impairment-prevention-bundle"},{"source_artifact_id":"wiki-ideas-senolytic-prevention-protocol","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-senolytic-prevention-protocol"},{"source_artifact_id":"wiki-ideas-novel-therapy-index","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-novel-therapy-index"},{"source_artifact_id":"wiki-ideas-payload-base-editing-apoe4","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/ideas-payload-base-editing-apoe4"},{"source_artifact_id":"wiki-ideas-gpnmb-lipid-laden-microglia","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/ideas-gpnmb-lipid-laden-microglia"},{"source_artifact_id":"wiki-ideas-payload-simufilam-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/ideas-payload-simufilam-therapy"},{"source_artifact_id":"wiki-ideas-circadian-entrainment-neuroprevention","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-circadian-entrainment-neuroprevention"},{"source_artifact_id":"wiki-ideas-prodromal-resilience-package","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-prodromal-resilience-package"},{"source_artifact_id":"wiki-ideas-glymphatic-clearance-enhancement","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-glymphatic-clearance-enhancement"},{"source_artifact_id":"wiki-ideas-payload-anti-herpetic-viral-therapy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-payload-anti-herpetic-viral-therapy-neurodegeneration"},{"source_artifact_id":"wiki-ideas-microbiome-guided-prevention-bundle","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/ideas-microbiome-guided-prevention-bundle"},{"source_artifact_id":"wiki-investment-aav-gene-therapy","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/investment-aav-gene-therapy"},{"source_artifact_id":"wiki-cell-types-microglial-cells-hierarchy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/cell-types-microglial-cells-hierarchy"},{"source_artifact_id":"wiki-cell-types-apoe-expressing-astrocytes","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 21x in wiki/cell-types-apoe-expressing-astrocytes"},{"source_artifact_id":"wiki-cell-types-ipsc-derived-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 14x in wiki/cell-types-ipsc-derived-microglia"},{"source_artifact_id":"wiki-cell-types-lipid-loaded-microglia","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/cell-types-lipid-loaded-microglia"},{"source_artifact_id":"wiki-cell-types-inferior-colliculus-auditory","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 21x in wiki/cell-types-inferior-colliculus-auditory"},{"source_artifact_id":"wiki-cell-types-brain-pericytes-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/cell-types-brain-pericytes-neurodegeneration"},{"source_artifact_id":"wiki-cell-types-synaptic-boutons","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: SREBF1 mentioned 2x in wiki/cell-types-synaptic-boutons"},{"source_artifact_id":"wiki-mechanisms-cbs-frontal-cortical-involvement","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-cbs-frontal-cortical-involvement"},{"source_artifact_id":"wiki-mechanisms-cbs-parietal-cortical-degeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-cbs-parietal-cortical-degeneration"},{"source_artifact_id":"wiki-mechanisms-fxr-signaling-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: CYP7A1 mentioned 3x in wiki/mechanisms-fxr-signaling-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-pericyte-loss","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/mechanisms-pericyte-loss"},{"source_artifact_id":"wiki-mechanisms-cerebral-amyloid-angiopathy-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 8x in wiki/mechanisms-cerebral-amyloid-angiopathy-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-synaptic-dysfunction-hypothesis","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 10x in wiki/mechanisms-synaptic-dysfunction-hypothesis"},{"source_artifact_id":"wiki-mechanisms-amyloid-hypothesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-amyloid-hypothesis"},{"source_artifact_id":"wiki-mechanisms-locus-coeruleus-degeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-locus-coeruleus-degeneration"},{"source_artifact_id":"wiki-mechanisms-axonal-transport-dysfunction-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/mechanisms-axonal-transport-dysfunction-comparison"},{"source_artifact_id":"wiki-mechanisms-bbb-breakdown-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 9x in wiki/mechanisms-bbb-breakdown-ad"},{"source_artifact_id":"wiki-mechanisms-metabolic-dysfunction-alzheimers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 8x in wiki/mechanisms-metabolic-dysfunction-alzheimers"},{"source_artifact_id":"wiki-mechanisms-lipid-dysregulation-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-lipid-dysregulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-vascular-dementia-mechanisms","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 10x in wiki/mechanisms-vascular-dementia-mechanisms"},{"source_artifact_id":"wiki-mechanisms-apoe-lipid-metabolism-alzheimers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-apoe-lipid-metabolism-alzheimers"},{"source_artifact_id":"wiki-mechanisms-neurovascular-ad-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 11x in wiki/mechanisms-neurovascular-ad-pathway"},{"source_artifact_id":"wiki-mechanisms-microglial-synaptic-pruning-dysregulation","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/mechanisms-microglial-synaptic-pruning-dysregulation"},{"source_artifact_id":"wiki-mechanisms-blood-brain-barrier-breakdown-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-blood-brain-barrier-breakdown-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-neurogenesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-neurogenesis"},{"source_artifact_id":"wiki-mechanisms-mtor-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-mtor-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-sleep-circadian-dysfunction-alzheimers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-sleep-circadian-dysfunction-alzheimers"},{"source_artifact_id":"wiki-mechanisms-cortisol-tau-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-cortisol-tau-pathway"},{"source_artifact_id":"wiki-mechanisms-sex-specific-mechanisms-alzheimers","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-sex-specific-mechanisms-alzheimers"},{"source_artifact_id":"wiki-mechanisms-parkinsons-neuroinflammation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-parkinsons-neuroinflammation"},{"source_artifact_id":"wiki-mechanisms-transdiagnostic-proteomic-changes","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-transdiagnostic-proteomic-changes"},{"source_artifact_id":"wiki-mechanisms-calcium-dysregulation-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 7x in wiki/mechanisms-calcium-dysregulation-ad"},{"source_artifact_id":"wiki-mechanisms-bbb-breakdown-disease-driver","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 12x in wiki/mechanisms-bbb-breakdown-disease-driver"},{"source_artifact_id":"wiki-mechanisms-microglial-priming-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-microglial-priming-pathway"},{"source_artifact_id":"wiki-mechanisms-glia-neuron-crosstalk-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-glia-neuron-crosstalk-ad"},{"source_artifact_id":"wiki-mechanisms-cerebral-amyloid-angiopathy-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 9x in wiki/mechanisms-cerebral-amyloid-angiopathy-pathway"},{"source_artifact_id":"wiki-mechanisms-adrd-biomarker-heterogeneity-framework","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 9x in wiki/mechanisms-adrd-biomarker-heterogeneity-framework"},{"source_artifact_id":"wiki-mechanisms-cholinergic-degeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 10x in wiki/mechanisms-cholinergic-degeneration"},{"source_artifact_id":"wiki-mechanisms-ppar-signaling-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: CPT1A mentioned 4x in wiki/mechanisms-ppar-signaling-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-amyloid-clearance","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-amyloid-clearance"},{"source_artifact_id":"wiki-mechanisms-lrp1-apoe-signaling-cascade","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 8x in wiki/mechanisms-lrp1-apoe-signaling-cascade"},{"source_artifact_id":"wiki-mechanisms-autophagy-lysosomal-dysfunction","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-autophagy-lysosomal-dysfunction"},{"source_artifact_id":"wiki-mechanisms-abca1-cholesterol-efflux-apoe-lipidation-ad-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/mechanisms-abca1-cholesterol-efflux-apoe-lipidation-ad-causal-chain"},{"source_artifact_id":"wiki-mechanisms-microglia-disease-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-microglia-disease-comparison"},{"source_artifact_id":"wiki-mechanisms-microglial-polarization","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-microglial-polarization"},{"source_artifact_id":"wiki-mechanisms-ad-glymphatic-clearance-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-ad-glymphatic-clearance-pathway"},{"source_artifact_id":"wiki-mechanisms-amyloid-cascade-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-amyloid-cascade-pathway"},{"source_artifact_id":"wiki-mechanisms-ubiquitin-signatures-aggregation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: ACLY mentioned 2x in wiki/mechanisms-ubiquitin-signatures-aggregation"},{"source_artifact_id":"wiki-mechanisms-neuroimmune-genes-alzheimers-trem2-cd33-pld3","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-neuroimmune-genes-alzheimers-trem2-cd33-pld3"},{"source_artifact_id":"wiki-mechanisms-amyloid-pathology","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-amyloid-pathology"},{"source_artifact_id":"wiki-mechanisms-trem2-apoe-axis","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 22x in wiki/mechanisms-trem2-apoe-axis"},{"source_artifact_id":"wiki-mechanisms-omega-3-fatty-acid-signaling-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-omega-3-fatty-acid-signaling-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-alpha-synuclein-escrt-iii-inhibition","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-alpha-synuclein-escrt-iii-inhibition"},{"source_artifact_id":"wiki-mechanisms-prime-editing-neurodegenerative-diseases","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-prime-editing-neurodegenerative-diseases"},{"source_artifact_id":"wiki-mechanisms-locus-coeruleus-degeneration-hypothesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-locus-coeruleus-degeneration-hypothesis"},{"source_artifact_id":"wiki-mechanisms-metabolic-epigenetic-axis-neurodegeneration-synthesis","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-metabolic-epigenetic-axis-neurodegeneration-synthesis"},{"source_artifact_id":"wiki-mechanisms-bbb-dysfunction-vascular-ci","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 7x in wiki/mechanisms-bbb-dysfunction-vascular-ci"},{"source_artifact_id":"wiki-mechanisms-cerebral-amyloid-angiopathy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 7x in wiki/mechanisms-cerebral-amyloid-angiopathy"},{"source_artifact_id":"wiki-mechanisms-energy-metabolism-dysfunction-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-energy-metabolism-dysfunction-comparison"},{"source_artifact_id":"wiki-mechanisms-lrp1-mediated-ab-clearance","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-lrp1-mediated-ab-clearance"},{"source_artifact_id":"wiki-mechanisms-splice-modulation-neurodegeneration","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-splice-modulation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-amyloid-beta-oligomerization-pathway","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-amyloid-beta-oligomerization-pathway"},{"source_artifact_id":"wiki-mechanisms-lipid-peroxidation-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-lipid-peroxidation-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-autophagy-lysosomal-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-autophagy-lysosomal-comparison"},{"source_artifact_id":"wiki-mechanisms-brain-insulin-signaling","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-brain-insulin-signaling"},{"source_artifact_id":"wiki-mechanisms-neuroinflammation-ad-pd","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-neuroinflammation-ad-pd"},{"source_artifact_id":"wiki-mechanisms-neurovascular-gut-brain-axis-neurodegeneration-synthesis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-neurovascular-gut-brain-axis-neurodegeneration-synthesis"},{"source_artifact_id":"wiki-mechanisms-oxidative-stress-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-oxidative-stress-comparison"},{"source_artifact_id":"wiki-mechanisms-dashboard","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-dashboard"},{"source_artifact_id":"wiki-mechanisms-app-amyloid-beta-plaque-ad-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-app-amyloid-beta-plaque-ad-causal-chain"},{"source_artifact_id":"wiki-mechanisms-amyloid-beta-degradation-pathways","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-amyloid-beta-degradation-pathways"},{"source_artifact_id":"wiki-mechanisms-apoe-lipid-dysregulation-cognitive-decline-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 30x in wiki/mechanisms-apoe-lipid-dysregulation-cognitive-decline-causal-chain"},{"source_artifact_id":"wiki-mechanisms-blood-brain-barrier-biology","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-blood-brain-barrier-biology"},{"source_artifact_id":"wiki-mechanisms-clu-clusterin-amyloid-clearance-ad-causal-chain","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/mechanisms-clu-clusterin-amyloid-clearance-ad-causal-chain"},{"source_artifact_id":"wiki-mechanisms-lipid-peroxidation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-lipid-peroxidation"},{"source_artifact_id":"wiki-mechanisms-ganglioside-lipid-raft-4r-tauopathies","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-ganglioside-lipid-raft-4r-tauopathies"},{"source_artifact_id":"wiki-mechanisms-autophagy-lysosome-dysfunction","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-autophagy-lysosome-dysfunction"},{"source_artifact_id":"wiki-mechanisms-myelin-pathology-disease-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-myelin-pathology-disease-comparison"},{"source_artifact_id":"wiki-mechanisms-microglia-neuroinflammation","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-microglia-neuroinflammation"},{"source_artifact_id":"wiki-mechanisms-long-term-potentiation-impairment","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-long-term-potentiation-impairment"},{"source_artifact_id":"wiki-mechanisms-pericyte-dysfunction","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-pericyte-dysfunction"},{"source_artifact_id":"wiki-mechanisms-ad-ftd-tau-tdp-overlap-comparison","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-ad-ftd-tau-tdp-overlap-comparison"},{"source_artifact_id":"wiki-mechanisms-astrocyte-neuron-metabolic-coupling","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-astrocyte-neuron-metabolic-coupling"},{"source_artifact_id":"wiki-mechanisms-ad-prevention-vs-treatment","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-ad-prevention-vs-treatment"},{"source_artifact_id":"wiki-mechanisms-autophagy-lysosomal-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-autophagy-lysosomal-ad"},{"source_artifact_id":"wiki-mechanisms-amyloid-beta-fibril-formation-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-amyloid-beta-fibril-formation-pathway"},{"source_artifact_id":"wiki-mechanisms-ad-funding-evidence-alignment","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/mechanisms-ad-funding-evidence-alignment"},{"source_artifact_id":"wiki-mechanisms-tyrobp-dap12-microglia-pathway","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/mechanisms-tyrobp-dap12-microglia-pathway"},{"source_artifact_id":"wiki-mechanisms-precision-medicine-neurodegeneration","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-precision-medicine-neurodegeneration"},{"source_artifact_id":"wiki-mechanisms-trem2","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-trem2"},{"source_artifact_id":"wiki-mechanisms-rankings","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-rankings"},{"source_artifact_id":"wiki-mechanisms-ad-therapeutic-scorecard","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-ad-therapeutic-scorecard"},{"source_artifact_id":"wiki-technologies-brain-organoids","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/technologies-brain-organoids"},{"source_artifact_id":"wiki-technologies-crispr-cas9","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/technologies-crispr-cas9"},{"source_artifact_id":"wiki-technologies-ipsc-disease-models","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 6x in wiki/technologies-ipsc-disease-models"},{"source_artifact_id":"wiki-biomarkers-combination-biomarker-panels-ad","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/biomarkers-combination-biomarker-panels-ad"},{"source_artifact_id":"wiki-biomarkers-polygenic-risk-score-integration-panel","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/biomarkers-polygenic-risk-score-integration-panel"},{"source_artifact_id":"wiki-biomarkers-csf-pta217","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/biomarkers-csf-pta217"},{"source_artifact_id":"wiki-biomarkers-csf-pta181","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/biomarkers-csf-pta181"},{"source_artifact_id":"wiki-biomarkers-adpd-2026-precision-medicine-genetic-stratification","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 21x in wiki/biomarkers-adpd-2026-precision-medicine-genetic-stratification"},{"source_artifact_id":"wiki-entities-remternetug","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/entities-remternetug"},{"source_artifact_id":"wiki-entities-complement-system","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/entities-complement-system"},{"source_artifact_id":"wiki-entities-gantenerumab","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/entities-gantenerumab"},{"source_artifact_id":"wiki-entities-aduhelm","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 4x in wiki/entities-aduhelm"},{"source_artifact_id":"wiki-diagnostics-apoe-genotyping","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 14x in wiki/diagnostics-apoe-genotyping"},{"source_artifact_id":"wiki-experiments-cognitive-reserve-mechanisms-alzheimers","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/experiments-cognitive-reserve-mechanisms-alzheimers"},{"source_artifact_id":"wiki-experiments-tbi-alzheimers-mechanism","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/experiments-tbi-alzheimers-mechanism"},{"source_artifact_id":"wiki-experiments-prion-strain-selective-vulnerability","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/experiments-prion-strain-selective-vulnerability"},{"source_artifact_id":"wiki-diseases-alzheimers-genetic-variants","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/diseases-alzheimers-genetic-variants"},{"source_artifact_id":"wiki-diseases-apoe2","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 5x in wiki/diseases-apoe2"},{"source_artifact_id":"wiki-diseases-alzheimers-disease","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/diseases-alzheimers-disease"},{"source_artifact_id":"wiki-diseases-tauopathies-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/diseases-tauopathies-comparison"},{"source_artifact_id":"wiki-diseases-cerebrotendinous-xanthomatosis","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: CYP7A1 mentioned 2x in wiki/diseases-cerebrotendinous-xanthomatosis"},{"source_artifact_id":"wiki-diseases-cerebral-amyloid-angiopathy","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 8x in wiki/diseases-cerebral-amyloid-angiopathy"},{"source_artifact_id":"wiki-diseases-apoe3","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 16x in wiki/diseases-apoe3"},{"source_artifact_id":"wiki-diseases-vascular-cognitive-impairment","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/diseases-vascular-cognitive-impairment"},{"source_artifact_id":"wiki-diseases-alzheimers-parkinsons-comparison","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/diseases-alzheimers-parkinsons-comparison"},{"source_artifact_id":"wiki-diseases-trem2-variants-in-ad","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/diseases-trem2-variants-in-ad"},{"source_artifact_id":"wiki-diseases-lewy-body-dementia","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 3x in wiki/diseases-lewy-body-dementia"},{"source_artifact_id":"wiki-hypotheses-apoe-contributes-alzheimer's-disease-regulat","link_type":"mentions","strength":0.5,"evidence":"Content: APOE4 mentioned 55x in wiki/hypotheses-apoe-contributes-alzheimer's-disease-regulat"},{"source_artifact_id":"wiki-mechanisms-er-mitochondria-contact-sites","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/mechanisms-er-mitochondria-contact-sites"},{"source_artifact_id":"wiki-cell-types-entorhinal-cortex-layer-ii-neurons-ad","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/cell-types-entorhinal-cortex-layer-ii-neurons-ad"},{"source_artifact_id":"wiki-cell-types-entorhinal-cortex-layer-iii","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/cell-types-entorhinal-cortex-layer-iii"},{"source_artifact_id":"wiki-experiments-dlb-tau-copathology","link_type":"mentions","strength":0.44999999999999996,"evidence":"Content: APOE4 mentioned 2x in wiki/experiments-dlb-tau-copathology"}],"current_artifact_id":"experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51","is_canonical":true,"supersede_chain":["experiment-exp-3b7faafc-4bd9-407f-ae87-8cfbd6237e51"]}